Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 87 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Antifungal Agents [Clear All Filters]
Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections..
Expert Opin Pharmacother. 23(2), 175-199.
(2022). Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study..
J Antimicrob Chemother. 74(2), 532-533.
(2019). Disseminated mucormycosis in an adolescent kidney transplant recipient..
Kidney Int. 95(1), 236.
(2019). Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis..
Pediatr Infect Dis J. 38(1), 42-49.
(2019). Invasive Fungal Infections in the Pediatric Intensive Care Unit..
Pediatr Infect Dis J. 38(9), e216-e218.
(2019). A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age..
Pediatr Infect Dis J. 38(3), 275-279.
(2019). Saksenaea vasiformis infections: A case of an immunocompetent adult after mild injury and a literature review..
J Mycol Med. 29(3), 260-264.
(2019).
(2019). Alternative approaches to the therapeutic drug monitoring of prophylactic posaconazole in haematology patients..
J Mycol Med. 28(1), 65-69.
(2018). Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline..
Clin Microbiol Infect. 24 Suppl 1, e1-e38.
(2018). European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated .
J Antimicrob Chemother. 73(12), 3221-3230.
(2018). Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges..
Pediatr Infect Dis J. 37(12), 1309-1311.
(2018). Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis..
PLoS One. 13(4), e0193732.
(2018). Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study..
J Pediatr Hematol Oncol. 40(1), 22-26.
(2018). Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases..
Med Mycol. 55(3), 246-254.
(2017). Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century..
Med Mycol. 55(7), 691-704.
(2017). Challenges in the management of chronic pulmonary aspergillosis..
Med Mycol. 55(1), 63-68.
(2017). Chromoblastomycosis..
Clin Microbiol Rev. 30(1), 233-276.
(2017). Clinical hepatotoxicity associated with antifungal agents..
Expert Opin Drug Saf. 16(2), 149-165.
(2017). In vitro combination therapy with isavuconazole against Candida spp..
Med Mycol. 55(8), 859-868.
(2017). Micafungin alters the amino acid, nucleic acid and central carbon metabolism of Candida albicans at subinhibitory concentrations: novel insights into mechanisms of action..
J Antimicrob Chemother. 72(3), 712-716.
(2017). Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study..
Mycoses. 60(12), 830-835.
(2017). A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study..
Clin Microbiol Infect. 23(10), 776.e1-776.e5.
(2017). Diagnosis of invasive fungal diseases in pediatric patients..
Expert Rev Anti Infect Ther. 14(12), 1203-1213.
(2016).
(2016). Σελίδες
- 1
- 2
- 3
- 4
- επόμενη ›
- τελευταία »